Makoto Tsuiji

Dr. Makoto Tsuiji

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Journal of Immunological Methods
Verified
Journal Article
Closed access
TTThomas Tiller
Thomas Tiller
EMEric Meffre
Eric Meffre
SYSergey Yurasov
Sergey Yurasov
MTMakoto Tsuiji
Makoto Tsuiji
MNMichel C. Nussenzweig
Michel C. Nussenzweig
HWHedda Wardemann
Hedda Wardemann

28 February 2005 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SYSergey Yurasov
Sergey Yurasov
HWHedda Wardemann
Hedda Wardemann
JHJohanna Hammersen
Johanna Hammersen
MTMakoto Tsuiji
Makoto Tsuiji
EMEric Meffre
Eric Meffre
MNMichel C. Nussenzweig
Michel C. Nussenzweig
A cardinal feature of systemic lupus erythematosus (SLE) is the development of autoantibodies. The first autoantibodies described in patients with SLE were those specific for nuclei and DNA, but subsequent work has shown that individuals with this disease produce a panoply of different autoantibodies. Thus, one of the constant features of SLE is a profound breakdown in tolerance in the antibody system. The appearance of self-reactive antibodies in SLE precedes clinical disease, but where in the B cell pathway tolerance is first broken has not been defined. In healthy humans, autoantibodies are removed from the B cell repertoire in two discrete early checkpoints in B cell development. We found these checkpoints to be defective in three adolescent patients with SLE. 25–50% of the mature naive B cells in SLE patients produce self-reactive antibodies even before they participate in immune responses as compared with 5–20% in controls. We conclude that SLE is associated with abnormal early B cell tolerance.

1 February 2007 in Immunity
Verified
Journal Article
Closed access
TTThomas Tiller
Thomas Tiller
MTMakoto Tsuiji
Makoto Tsuiji
SYSergey Yurasov
Sergey Yurasov
KVKlara Velinzon
Klara Velinzon
MNMichel C. Nussenzweig
Michel C. Nussenzweig
HWHedda Wardemann
Hedda Wardemann

15 March 2004 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
ATAyato Takada
Ayato Takada
KFKouki Fujioka
Kouki Fujioka
MTMakoto Tsuiji
Makoto Tsuiji
AMAkiko Morikawa
Akiko Morikawa
NHNobuaki Higashi
Nobuaki Higashi
YKYoshihiro Kawaoka
Yoshihiro Kawaoka
Filoviruses cause lethal hemorrhagic disease in humans and nonhuman primates. An initial target of filovirus infection is the mononuclear phagocytic cell. Calcium-dependent (C-type) lectins such as dendritic cell- or liver/lymph node-specific ICAM-3 grabbing nonintegrin (DC-SIGN or L-SIGN, respectively), as well as the hepatic asialoglycoprotein receptor, bind to Ebola or Marburg virus glycoprotein (GP) and enhance the infectivity of these viruses in vitro. Here, we demonstrate that a recently identified human macrophage galactose- andN-acetylgalactosamine-specific C-type lectin (hMGL), whose ligand specificity differs from DC-SIGN and L-SIGN, also enhances the infectivity of filoviruses. This enhancement was substantially weaker for the Reston and Marburg viruses than for the highly pathogenic Zaire virus. We also show that the heavily glycosylated, mucin-like domain on the filovirus GP is required for efficient interaction with this lectin. Furthermore, hMGL, like DC-SIGN and L-SIGN, is present on cells known to be major targets of filoviruses (i.e., macrophages and dendritic cells), suggesting a role for these C-type lectins in viral replication in vivo. We propose that filoviruses use different C-type lectins to gain cellular entry, depending on the cell type, and promote efficient viral replication.

15 July 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BMBrun Mietzner
Brun Mietzner
MTMakoto Tsuiji
Makoto Tsuiji
JSJohannes Scheid
Johannes Scheid
KVKlara Velinzon
Klara Velinzon
TTThomas Tiller
Thomas Tiller
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Persistent autoantibody production in patients with systemic lupus erythematosus (SLE) suggests the existence of autoreactive humoral memory, but the frequency of self-reactive memory B cells in SLE has not been determined. Here, we report on the reactivity of 200 monoclonal antibodies from single IgG+ memory B cells of four SLE patients. The overall frequency of polyreactive and HEp-2 self-reactive antibodies in this compartment was similar to controls. We found 15% of IgG memory B cell antibodies highly reactive and specific for SLE-associated extractable nuclear antigens (ENA) Ro52 and La in one patient with serum autoantibody titers of the same specificity but not in the other three patients or healthy individuals. The germ-line forms of the ENA antibodies were non-self-reactive or polyreactive with low binding to Ro52, supporting the idea that somatic mutations contributed to autoantibody specificity and reactivity. Heterogeneity in the frequency of memory B cells expressing SLE-associated autoantibodies suggests that this variable may be important in the outcome of therapies that ablate this compartment.

31 August 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YAYu Adachi
Yu Adachi
TOTaishi Onodera
Taishi Onodera
YYYuki Yamada
Yuki Yamada
RDRina Daio
Rina Daio
MTMakoto Tsuiji
Makoto Tsuiji
YTYoshimasa Takahashi
Yoshimasa Takahashi
Respiratory influenza virus infection induces cross-reactive memory B cells targeting invariant regions of viral escape mutants. However, cellular events dictating the cross-reactive memory B cell responses remain to be fully defined. Here, we demonstrated that lung-resident memory compartments at the site of infection, rather than those in secondary lymphoid organs, harbor elevated frequencies of cross-reactive B cells that mediate neutralizing antibody responses to viral escape. The elevated cross-reactivity in the lung memory compartments was correlated with high numbers of VH mutations and was dependent on a developmental pathway involving persistent germinal center (GC) responses. The persistent GC responses were focused in the infected lungs in association with prolonged persistence of the viral antigens. Moreover, the persistent lung GCs supported the exaggerated B cell proliferation and clonal selection for cross-reactive repertoires, which served as the predominant sites for the generation of cross-reactive memory progenitors. Thus, we identified the distinct GC selection at local sites as a key cellular event for cross-reactive memory B cell response to viral escape, a finding with important implications for developing broadly protective influenza vaccines.